Ironwood, Forest 'Rooting' for Added Success In IBS Therapeutics Daily (press release) (registration) Amsellem wrote, "We believe the IBS-C studies are riskier than the CC [chronic constipation] studies, given the high incidence of placebo responses ... Ironwood and Forest Announce Positive Linaclotide Results from Two Pivotal ... TOP MARKET NEWS Ironwood, Forest Labs Drug for Chronic Constipation Passes Two Pivotal Trials |
View the full article

Help





MultiQuote








